Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11-12
|
pubmed:dateCreated |
1991-7-15
|
pubmed:abstractText |
Two naturally occurring lignanolides, isolated from the tropical climbing shrub Ipomoea cairica, (-)-arctigenin and (-)-trachelogenin, were found to inhibit strongly replication of human immunodeficiency virus type 1 (HIV-1; strain HTLV-III B) in vitro. At a concentration of 0.5 microM, (-)-arctigenin and (-)-trachelogenin inhibited the expression of HIV-1 proteins p17 and p24 by 80-90% and 60-70%, respectively. The reverse transcriptase activity in the culture fluids was reduced by 80-90% when the cells (HTLV-III B/H9) were cultivated in the presence of 0.5 microM (-)-arctigenin or 1 microM (-)-trachelogenin. At the same concentrations, the formation of syncytia in the HTLV-III B/H9-Jurkat cell system was inhibited by the compounds by more than 80%. A series of other lignan type compounds displayed no anti-HIV activity. Studying the molecular mechanism of action of (-)-arctigenin and (-)-trachelogenin we found that both compounds are efficient inhibitors of the nuclear matrix-associated DNA topoisomerase II activity, particularly of the enzyme from HIV-1-infected cells. Our results suggest that both compounds prevent the increase of topoisomerase II activity, involved in virus replication, after infection of cells with HIV-1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type II,
http://linkedlifedata.com/resource/pubmed/chemical/Lignans,
http://linkedlifedata.com/resource/pubmed/chemical/Lignin,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0939-5075
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1215-21
|
pubmed:dateRevised |
2009-11-4
|
pubmed:meshHeading |
pubmed-meshheading:1965681-Animals,
pubmed-meshheading:1965681-Antiviral Agents,
pubmed-meshheading:1965681-Cell Division,
pubmed-meshheading:1965681-Cell Line,
pubmed-meshheading:1965681-DNA Topoisomerases, Type II,
pubmed-meshheading:1965681-HIV,
pubmed-meshheading:1965681-HIV-1,
pubmed-meshheading:1965681-Humans,
pubmed-meshheading:1965681-Leukemia L5178,
pubmed-meshheading:1965681-Lignans,
pubmed-meshheading:1965681-Lignin,
pubmed-meshheading:1965681-Mice,
pubmed-meshheading:1965681-Plasmids,
pubmed-meshheading:1965681-Structure-Activity Relationship,
pubmed-meshheading:1965681-Viral Proteins
|
pubmed:articleTitle |
Differential in vitro anti-HIV activity of natural lignans.
|
pubmed:affiliation |
Abteilung Angewandte Molekularbiologie, Universität Mainz, Bundesrepublik Deutschland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|